scholarly journals Management of monomorphic ventricular tachycardia electrical storm in structural heart disease

2019 ◽  
Vol 31 (3) ◽  
pp. 135-144
Author(s):  
Ahmed AlKalbani ◽  
Najib AlRawahi
ESC CardioMed ◽  
2018 ◽  
pp. 2279-2288
Author(s):  
Tilman Maurer ◽  
William G. Stevenson ◽  
Karl-Heinz Kuck

Monomorphic ventricular tachycardia (VT) may occur in the presence or absence of structural heart disease. The standard therapy for patients with structural heart disease at high risk of sudden cardiac death due to VT is the implantable cardioverter defibrillator (ICD). While ICDs effectively terminate VT and prevent sudden cardiac death, they do not prevent recurrent episodes of VT, since the underlying arrhythmogenic substrate remains unchanged. However, shocks from an ICD increase mortality and impair quality of life. These limitations as well as continuous advancements in technology have made catheter ablation an important treatment strategy for patients with structural heart disease presenting with VT. Idiopathic ventricular arrhythmias include premature ventricular contractions and VT occurring in the absence of overt structural heart disease. In this setting, catheter ablation has evolved as the primary therapeutic option for symptomatic ventricular premature beats and sustained VTs and is curative in most cases. This chapter presents an overview of the principles of invasive diagnosis and treatment of monomorphic VTs in patients with and without structural heart disease and delineates the clinical outcome of catheter ablation. Finally, the chapter provides an outlook to the future, discussing potential directions and upcoming developments in the field of catheter ablation of monomorphic VT.


EP Europace ◽  
2018 ◽  
Vol 20 (suppl_1) ◽  
pp. i42-i42
Author(s):  
S Mathew ◽  
T Maurer ◽  
C Lemes ◽  
C Heeger ◽  
B Reissmann ◽  
...  

2011 ◽  
Vol 27 (Supplement) ◽  
pp. OP06_3
Author(s):  
Hiroshi Furushima ◽  
Masaomi Chinushi ◽  
Keiko Sonoda ◽  
Kanae Hasegawa ◽  
Nobue Yagihara ◽  
...  

ESC CardioMed ◽  
2018 ◽  
pp. 2265-2270
Author(s):  
Fernando M. Contreras-Valdes ◽  
Peter J. Zimetbaum

Sustained monomorphic ventricular tachycardia occurs in patients with structural heart disease and may lead to syncope, haemodynamic collapse, or sudden death. The diagnosis is established by the electrocardiogram, with cardiac imaging used to determine the underlying substrate. Initial management requires a combination of electrical cardioversion and antiarrhythmic drugs, mainly amiodarone and beta blockers. Nonetheless, implantable cardioverter defibrillators provide the most substantial reduction in sudden death, with catheter ablation becoming an increasingly favoured strategy to minimize shocks and possibly lower mortality from ventricular arrhythmias in this population.


PLoS ONE ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. e0171830 ◽  
Author(s):  
Bashar Aldhoon ◽  
Dan Wichterle ◽  
Petr Peichl ◽  
Robert Čihák ◽  
Josef Kautzner

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Daniel H. Wolbrom ◽  
Aleef Rahman ◽  
Cory M. Tschabrunn

Nonpenetrating, blunt chest trauma is a serious medical condition with varied clinical presentations and implications. This can be the result of a dense projectile during competitive and recreational sports but may also include other etiologies such as motor vehicle accidents or traumatic falls. In this setting, the manifestation of ventricular arrhythmias has been observed both acutely and chronically. This is based on two entirely separate mechanisms and etiologies requiring different treatments. Ventricular fibrillation can occur immediately after chest wall injury (commotio cordis) and requires rapid defibrillation. Monomorphic ventricular tachycardia can develop in the chronic stage due to underlying structural heart disease long after blunt chest injury. The associated arrhythmogenic tissue may be complex and provides the necessary substrate to form a reentrant VT circuit. Ventricular tachycardia in the absence of overt structural heart disease appears to be focal in nature with rapid termination during ablation. Regardless of the VT mechanism, patients with recurrent episodes, despite antiarrhythmic medication in the chronic stage following blunt chest injury, are likely to require ablation to achieve VT control. This review article will describe the mechanisms, pathophysiology, and treatment of ventricular arrhythmias that occur in both the acute and chronic stages following blunt chest trauma.


2019 ◽  
Vol 5 (1) ◽  
pp. 13-24 ◽  
Author(s):  
Jorge Romero ◽  
Roberto C. Cerrud-Rodriguez ◽  
Luigi Di Biase ◽  
Juan Carlos Diaz ◽  
Isabella Alviz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document